GB Patent

GB8507058D0 — Pharmaceutical & dietary compositions

Assigned to Efamol Ltd · Expires 1985-04-24 · 41y expired

What this patent protects

Gamma-linolenic acid or dihomo-gamma-linolenic acid for use in the reduction or prevention of gastro-intestinal bleeding and other side effects shown by NSAIDs when adminsitered on a continuing basis, including use in allowing said administration to be replaced by administration …

USPTO Abstract

Gamma-linolenic acid or dihomo-gamma-linolenic acid for use in the reduction or prevention of gastro-intestinal bleeding and other side effects shown by NSAIDs when adminsitered on a continuing basis, including use in allowing said administration to be replaced by administration of said acid alone in arthritis and other conditions without exacerbation of symptoms.

Drugs covered by this patent

Patent Metadata

Patent number: GB8507058D0
Jurisdiction: GB
Classification: —
Expires: 1985-04-24
Drug substance claim: No
Drug product claim: No
Assignee: Efamol Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.